Bendamustine-induced "flagellate dermatitis"

Abstract

Background: The term "flagellate erythema" after bleomycin therapy was described as bleomycin-induced linear hyperpigmentation. Since then, this pattern has not been related to any other chemotherapeutic regimen.

Observation: We report a rare patient with chronic lymphocytic leukemia who developed "flagellate dermatitis" induced by bendamustine.

Conclusion: Chemotherapy induced "Flagellate Dermatitis" is a rare finding reported only after bleomycin therapy. We describe the first case with this characteristic eruption pattern after administration of bendamustine.